– USA, NY – Cedar, the patient engagement and financial technology leader, today announced it has closed more than $102M in Series C funding, led by venture capital firm Andreessen Horowitz.
The deal includes $77M in venture capital and $25M from JP Morgan in venture debt. This round brings Cedar’s total capital raise to $157M to date.
As part of the financing, Scott Kupor, Andreessen Horowitz Managing Partner, will join the board of directors.
The company also announced it has partnered with Novant Health, a leading North Carolina-based healthcare system, to deliver an innovative, personalized financial experience for Novant Health patients.
“The COVID-19 pandemic has put a spotlight on many of the inefficiencies and archaic processes across our current healthcare system which has, in turn, driven an increase in the adoption of platforms like Cedar’s among healthcare providers,” said CEO and co-founder, Florian Otto. “Through this round of funding and our new partnership with Novant Health, Cedar’s patient engagement and payment technology platform will be able to offer an improved experience for more patients with simplified and personalized digital engagement strategies and payment support options. We’re very pleased with this strong show of support from our investors and partners, and look forward to further enhancing our platform for patients and providers.”
To support Cedar’s rapid growth, the latest round of funding will be used to invest in expanding the company’s reach and to accelerate product innovation and expansion. Other participants in the fundraising round include Kaiser Permanente and individual angel investors including Jerod Mayo, linebacker coach for the New England Patriots and Jeff Vacirca, MD, FACP and CEO of New York Cancer & Blood Specialists, as well as Cedar’s current investors including Kinnevik, Thrive Capital, Lakestar and Founders Fund.
“Cedar’s leadership team brings together medical, healthcare technology and deep software expertise that puts them in a unique position to drastically transform the way patients interact with healthcare providers,” said Kupor. “We’ve been extremely impressed by the patient payment solutions they’ve built and look forward to partnering to help them deliver on their mission to allow healthcare providers to understand and engage with patients more effectively.”
This past year, and even more so since the global COVID-19 pandemic, Cedar has expanded rapidly with innovative partnerships and collaborations with institutions like Novant Health, seeking to improve patient satisfaction and financial results, so they can continue to deliver the highest standards of care. Novant will roll out Cedar’s patient engagement and payment technology platform to modernize the payment experience for its patients across the network. Novant Health’s partnership with Cedar will also advance and accelerate key innovation initiatives that extend further into pre-visit patient digital engagement.
“At Novant Health, we are always looking at how we can implement new technology to create a world-class consumer experience for our patients,” said Geoffrey Gardner, senior vice president of operational finance and revenue cycle at Novant Health. “By selecting Cedar as an innovation partner to transform our payment process, we are committed to using technology to make health care costs and billing more understandable, personalized and convenient.”
Novant Health and Cedar expect to roll-out the new engagement and billing platform before the end of 2020.
About Cedar
Recently named the most innovative healthcare tech company of 2020, according to a KLAS survey of 300 healthcare executives, Cedar is a healthcare financial engagement platform for hospitals, health systems and medical groups that clarifies and simplifies the financial experience for patients, improving bill resolution and payment outcomes for providers. Using intuitive design and advanced data science, Cedar facilitates patient-centric financial engagement across the care journey.
For more information: https://www.cedar.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
